March 31, 2021
Re: Revision to the QTdrugs List
We are writing to inform you that two newly marketed drugs in the US, Ponesimod for treatment of multiple sclerosis and Voclosporin for treatment of lupus nephritis, have been added to the Possible Risk of TdP category.
Also, if you haven’t already, we hope you will try AZCERT’s web-based decision support program, MedSafety Scan®. It is available at MedSafetyScan.org to help healthcare providers quickly assess a patient’s risk of QT prolongation and detect potentially dangerous drug-drug interactions.
The features of MedSafety Scan are described in detail in a recent article published in Trends in Cardiovascular Medicine titled Assisted prescribing: Clinical decision support with MedSafety Scan.
Thank you for your interest and continued support of CredibleMeds.
Ray Woosley and the Scientific Review Committee
Scientific Review Committee Raymond L. Woosley, MD, PhD
Klaus Romero, MD, MS
C.Will Heise, MD
Tyler Gallo, PharmD
Jared Tate, PharmD
David Woosley, MPH
Members with cardiac conditions may like to consider registering with CredibleMeds to be kept up to date with any changes to the QT drugs to avoid list https://crediblemeds.org/everyone/
